Brentuximab Interactions
There are 647 drugs known to interact with brentuximab, along with 8 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 67 are major, and 580 are moderate.
- View all 647 medications that may interact with brentuximab
- View brentuximab alcohol/food interactions (2)
- View brentuximab disease interactions (8)
Most frequently checked interactions
View interaction reports for brentuximab and the medicines listed below.
- Adriamycin (doxorubicin)
- Advil (ibuprofen)
- Aleve (naproxen)
- Ambien (zolpidem)
- Ativan (lorazepam)
- Augmentin (amoxicillin / clavulanate)
- Bactrim (sulfamethoxazole / trimethoprim)
- Benadryl (diphenhydramine)
- Claritin (loratadine)
- Eliquis (apixaban)
- Equate Sleep Aid (doxylamine)
- L-Arginine (arginine)
- L-Carnitine (levocarnitine)
- L-Cysteine (cysteine)
- Lipitor (atorvastatin)
- Lithium Carbonate ER (lithium)
- Metoprolol Succinate ER (metoprolol)
- Neulasta (pegfilgrastim)
- Phillips' Milk of Magnesia (magnesium hydroxide)
- Prilosec OTC (omeprazole)
- Protonix (pantoprazole)
- Tylenol (acetaminophen)
- Tylenol Extra Strength (acetaminophen)
- Valproate Sodium (valproic acid)
- Vitamin B1 (thiamine)
- Vitamin B12 (cyanocobalamin)
- Vitamin B6 (pyridoxine)
- Vitamin D3 (cholecalciferol)
- Vitamin K (phytonadione)
- Vitamin K2 (menaquinone)
Brentuximab alcohol/food interactions
There are 2 alcohol/food interactions with brentuximab.
Brentuximab disease interactions
There are 8 disease interactions with brentuximab which include:
- infections
- tumor lysis syndrome
- hepatotoxicity
- hyperglycemia
- peripheral neuropathy
- pulmonary toxicity
- renal impairment
- Brentuximab vedotin -GI events
Report options
More about brentuximab
- brentuximab consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: CD30 monoclonal antibodies
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Decadron
Decadron is used for addison's disease, adrenal insufficiency, adrenocortical insufficiency ...
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Revlimid
Revlimid is used to treat types of multiple myeloma, mantle cell lymphoma, follicular lymphoma and ...
Nivolumab
Nivolumab (brand name Opdivo) is an immunotherapy treatment that treats many cancers, such as ...
Cyclophosphamide
Cyclophosphamide systemic is used for acute lymphocytic leukemia, acute nonlymphocytic leukemia ...
Rituximab
Rituximab infusion is used to treat certain leukemias and lymphomas and some non-cancer conditions ...
Pembrolizumab
Pembrolizumab (Keytruda) is a monoclonal antibody cancer medicine used to treat
Dexamethasone
Dexamethasone is used to treat inflammatory conditions such as allergies, skin conditions ...
Methotrexate
Methotrexate is used to treat certain types of cancer of the breast, skin, head and neck, or lung ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.